GLP-1 C + GLP-1 S

Cagrilintide + Semaglutide – 10mg (Lyophilized Peptide Blend) – For Research Use Only

The combination of Cagrilintide and Semaglutide brings together two powerful peptides studied for their potential synergistic effects on appetite regulation, weight management, and metabolic health.

• Cagrilintide is an amylin analog researched for its role in promoting satiety and reducing food intake.

• Semaglutide is a GLP-1 receptor agonist studied for its effects on appetite suppression, glucose regulation, and insulin sensitivity.

This dual peptide blend is highly regarded in research models focused on obesity, metabolic syndrome, and energy balance.

Product Details:

• Peptides: Cagrilintide + Semaglutide (5mg each unless otherwise specified)

• Purity: >98%

• Form: Lyophilized powder

• Quantity: 10mg per vial

• Storage: Store at -4°F (-20°C). After reconstitution, refrigerate at 36–46°F (2–8°C) and use within 30 days.

• Grade: For research purposes only. Not for human consumption, therapeutic, or diagnostic use.

Potential Research Applications:

• Appetite suppression and satiety studies

• Obesity and weight management models

• Metabolic health and insulin sensitivity research

• Dual pathway hormone modulation investigations

For laboratory research use only. This product is not intended to diagnose, treat, cure, or prevent any disease.